Crossmark

Drug development for newborn brain injury

Crossref DOI link: https://doi.org/10.1038/s41390-026-05142-w

Published Online: 2026-05-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maltepe, Emin https://orcid.org/0000-0002-1271-7565
License Information

Text and Data Mining valid from 2026-05-22

Version of Record valid from 2026-05-22
More Information

Article History

Received: 22 April 2026

Accepted: 7 May 2026

First Online: 22 May 2026

Competing interests

: Scientific Advisory Board, Vessel Sciences, Inc., consultant, Third Pole, Inc., Omniox, Inc., Advisor, Amnion Life, Inc.